The precise mechanism by which DARPP-32 exerts its influence on breast cancer remains poorly understood, nevertheless, current evidence suggests that DARPP-32 may act as a key regulator and/or activator of several critical signalling pathways implicated in cancer development and progression. The gene discussed is PPP1R1B; the disease is cancer.